Andrew Miller, EVP, CFO at CEPHEID (CPHD), sold 63,375 shares at $52.95 ($3.4M) on 2014-01-31, disclosed to the SEC on 2014-02-03.
Scheduled sale ($3.4M) by EVP, CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.95 | 21,750 | $1.1M | 33.6% |
| 2 | $52.95 | 2,250 | $119K | 3.5% |
| 3 | $53.75 | 39,375 | $2.1M | 62.9% |
| Total | $53.10 avg | 63,375 | $3.4M | 100% |
| Filing → |
| IRBT | SELL | 2020-12-11 | $137K | — | Filing → |
| IRBT | SELL | 2020-06-09 | $74K | — | Filing → |
| IRBT | SELL | 2019-12-11 | $20K | — | Filing → |